Discrepancy between 99mTc-HMPAO and 99mTc-ECD in Alzheimer's disease: Does the retention mechanism depend on the disease?

Kakuigaku

Volumn 35, Issue 8, 1998, Pages 719-720

  Komatani, Akio ^a   Sugai, Yukio ^a   Watanabe, Nami ^a   Yamaguchi, Koichi ^a   Kawakatsu, Shinobu ^b  

^a YAMAGATA UNIVERSITY   (Japan)

^b NONE

Author keywords

133Xe; 99mTc ECD; 99mTc HMPAO; Alzheimer's disease; Regional cerebral blood flow

Indexed keywords

CYSTEINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; ESTERASE; GLUTATHIONE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M BICISATE; XENON; CYSTEINE ETHYL ESTER TC 99M;

ALZHEIMER DISEASE; ARTICLE; BRAIN; BRAIN CIRCULATION; COMPARATIVE STUDY; HUMAN; METABOLISM; PATHOPHYSIOLOGY; SCINTISCANNING; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; ENZYME ACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; CYSTEINE; ESTERASES; GLUTATHIONE; HUMANS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; XENON RADIOISOTOPES;

EID: 84865918944     PISSN: 00227854     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. 18F-fluoromethane PET in cerebrovascular disease. J Cereb Blood Flow Metab 10: 687-697, 1990
2. 99mTc-d,1-HMPAO in the human brain after increased bolus injection: A kinetic analysis. J Cereb Blood Flow Metab 8: s13-s22, 1988
3. 99mTc-d,1-hexamethyl-propyleneamine oxime (HMPAO) compared with regional cerebral blood flow measured by PET: Effects of linearization. J Cereb Blood Flow Metab 8: s82-s89, 1988
4. Kanno I, Lassen NA: Two methods for calculating regional cerebrel blood flow from emission computed tomography of inert gas concentrations. J Comput Assist Tomogr 3: 71-76, 1979
5. Dyck CH, Lin CH, Smith EO, Wisniewski G, Cellar J, Robinson R, et al: Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease. J Nucl Med 37: 1749-1755, 1996
6. Nierinckx RD, Burke JF, Harrison RC, Forster AM, Anderson AR, Lassen NA: The retention mechanism of technetium-99m-HMPAO: Intracellular reaction with glutathione. J Cereb Blood Flow Metab 8: S4-S12, 1988
7. Ballinger JR, Reid RH, Gulenchyn KY: Technetium-99m HM-PAO stereoisomers: Differences in interaction with glutathione. J Nucl Med 29: 1998-2000, 1988
8. Jacquier MR, Polla BS, Sloaman DO: Oxide-reductive state; The major determinant for cellular retention of Technetium-99m-HMPAO. J Nucl Med 37: 143-146, 1996
9. ) Jacquier MR, Polla BS, Sloaman DO: Cellular basis of ECD brain retention. J Nucl Med 37: 1694-1697, 1996
10. Davis P, Maloney AFJ: Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1043, 1976
11. Koshumura K, Kato T, Tohyama I: Quantitative abnormalities of choline acetyltransferase in Alzheimer type dementia. J Neurol Sci 76: 143-150, 1986
12. Nakano S, Kato T, Nakamura S: Acetylcholine-esterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia. J Neurol Sci 75: 213-223, 1985